letrozole,palbociclib
pfizer,novartis
['bcsm', 'paloma-2', 'mbc']
os data from paloma-2 os not statistically significant although numerically longer, even after excluding missing data. no new safety concerns after&gt;7yrs of follow up. 10% of pts still on treatment arm (palbo+ letrozole) #bcsm #asco22 #mbc 
Breast Medical Oncologist @RutgersCancer @Rutgers and @RWJMS wife/mom/baker/world traveler #bcsm